A Clinical Trial to Compare Etrolizumab with Infliximab in Patients with Moderate to Severe Ulcerative Colitis Who Have not Received Treatment with Tumour Necrosis Factor Inhibitors (Gardenia)

A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) Inhibitors

Autoimmune Disorder
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis

Results
Download

Study results

LPS_GA29103_GARDENIA_interim results_October2021_English (PDF, 0.7 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_cs (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(at) (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(de) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_es (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(ca) (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_he (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_hu (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_it (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_ko (PDF, 0.6 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(be) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(nl) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_no (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_pt (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_ro (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_sv(se) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(fr).pdf (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Clinical Trial to Compare Etrolizumab with Infliximab in Patients with Moderate to Severe Ulcerative Colitis Who Have not Received Treatment with Tumour Necrosis Factor Inhibitors (Gardenia)

Study results

LPS_GA29103_GARDENIA_interim results_October2021_English (PDF, 0.7 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_cs (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(at) (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_de(de) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_es (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(ca) (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_he (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_hu (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_it (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_ko (PDF, 0.6 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(be) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_nl(nl) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_no (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_pt (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_ro (PDF, 0.3 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_sv(se) (PDF, 0.4 MB)

LPS_GA29103_GARDENIA_final results_20Oct2021_English_fr(fr).pdf (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Clinical Trial to Compare Etrolizumab with Infliximab in Patients with Moderate to Severe Ulcerative Colitis Who Have not Received Treatment with Tumour Necrosis Factor Inhibitors (Gardenia)

For the latest version of this information please go to www.forpatients.roche.com